• Research Findings and Conclusion
Key players are involved in the research and development of novel drug therapy for the
treatment of duchenne muscular dystrophy (DMD):
Key players operating duchenne muscular dystrophy (DMD) treatment market includes SUMMIT
Therapeutics Plc., PTC Therapeutics, BioMarin Pharmaceuticals Incorporated, Sarepta
Therapeutics, Pfizer Incorporated, Pharmacia & Upjohn LLC, and others. Major industry players
are involved in the research and development of novel drugs for treatment, and strategies such
as collaboration and partnership are adopted by companies to hold the major share in the
duchenne muscular dystrophy (DMD) treatment market. For instance, PTC Therapeutics
International Limited has obtained conditional approval and orphan drug designation in 2014
for Translarna, which is a novel gene therapy for the treatment of duchenne muscular
dystrophy.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/898
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars,
called PHASE-XS. This database provides analytical data in addition to the clinical information
of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters,
PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend,
competition, and market potential. For more information or to access this database, kindly click
on the below link or contact at sales@coherentmarketinsights.com
https://www.coherentmarketinsights.com/phase-xs/
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200